Additionally, Receiver operating characteristic (ROC) analysis indicated that MAD2L2 expression levels could effectively distinguish between GBM and LGG (Fig. 1G), with GBM associated with poorer clinical prognosis. Here, MAD2L2 is linked to glioblastoma.